HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Esophageal atresia and tracheoesophageal fistula in two infants born to hyperthyroid women receiving methimazole (Tapazol) during pregnancy.

Abstract
We report on 2 newborn infants with esophageal atresia and tracheoesophageal fistula (EA + TEF) born to hyperthyroid mothers receiving methimazole (Tapazol) before and during their entire pregnancies. Both mothers were euthyroid during gestation and developed hydramnios diagnosed during weeks 34 and 33 of gestation. Premature delivery (36.2 weeks of gestation) occurred in one case, and both newborn infants were small for date with palpable goiter; one of them had other associated malformations. Hypothyroidism was diagnosed by laboratory tests in both cases. Corrective surgery was undertaken, but both newborn infants developed septicemia and renal insufficiency and died in the first week of life. The EA + TEF and a normally placed enlarged thyroid gland were confirmed at necropsy. These cases represent a previously unreported example of the association of maternal ingestion of methimazole during pregnancy and EA + TEF.
AuthorsA Ramírez, A Espinosa de los Monteros, A Parra, B De León
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 44 Issue 2 Pg. 200-2 (Sep 15 1992) ISSN: 0148-7299 [Print] United States
PMID1456292 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Methimazole
Topics
  • Abnormalities, Drug-Induced
  • Adult
  • Esophageal Atresia (chemically induced)
  • Female
  • Humans
  • Hyperthyroidism (complications, drug therapy)
  • Infant, Newborn
  • Male
  • Maternal-Fetal Exchange
  • Methimazole (adverse effects)
  • Pregnancy
  • Pregnancy Complications (drug therapy)
  • Tracheoesophageal Fistula (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: